Jung Hee Lee
Sungkyunkwan University · 医学
研究室紹介
Professor Jung Hee Lee's research lab specializes in the development of advanced nanomaterials and smart contrast agents for magnetic resonance imaging (MRI), with a focus on targeted, pH-responsive, and biocompatible systems for precise diagnostic imaging. The lab pioneers innovative surface engineering strategies for rare-earth and iron-based nanoparticles to enhance their stability, compatibility, and functionality in biological environments. Key research directions include the design of stimuli-responsive nanocarriers for tumor imaging and therapy, as well as the application of MRI techniques such as DCE-MRI to evaluate treatment efficacy in clinical settings like uterine fibroid ablation. The lab integrates materials science, biochemistry, and medical imaging to create next-generation diagnostic tools with high specificity and sensitivity.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15The development of nontoxic and biocompatible imaging agents will create new opportunities for potential applications in clinical MRI diagnosis. Synthetic melanin-like nanoparticles (MelNPs), analogous to natural sepia melanin (a major component of the cuttlefish ink), can be used as contrast agent for MRI. MelNPs complexed with paramagnetic Fe(3+) ions show much higher relaxivity values than existing MRI T1 contrast agents based on gadolinium (Gd) or manganese (Mn); MelNP values at 3T were r1 =
Kontrastreich: Ein T1-Kontrastmittel für die Kernspintomographie (MRI), das auf MnO-Nanopartikeln beruht, bewirkt eine große Signalverstärkung und macht aufgelöste anatomische Strukturen im T1-gewichteten MR-Bild eines Maushirns sichtbar (siehe Bild; links: MRI, rechts: MnO-verstärkte MRI (MONEMRI)). Mit einem tumorspezifischen Antikörper konjugierte MnO-Nanopartikel wurden zudem genutzt, um Brustkrebszellen in einer Metastase im Hirn selektiv abzubilden. Supporting information for this article
Abstract A novel method for modifying the surface of magnetic‐resonance‐contrasting layered gadolinium hydroxide (LGdH) is developed providing them with water‐ and bio‐compatibility and acid‐resistance, all of which are essential for medical applications. A stable colloid of exfoliated layers is synthesized by exchanging interlayer anions of LGdH with oleate ions. The delaminated layers are successively coated with phospholipids with poly(ethylene glycol) tail groups, and their effectiveness as
A facile and powerful pH-responsive polymeric micelle encapsulates Fe3O4 nanoparticles as an acid-targeting MRI contrast agent for pathologic diagnosis. This MRI probe remains in a micellar state in the physiological environment whereas it can be dissolved in acidic pathological areas. More biomedical applications will be possible owing to its unique ability to target an acidic pathologic environment.
A novel type of pH-responsive biodegradable copolymer was developed based on methyloxy-poly(ethylene glycol)-block-poly[dopamine-2-(dibutylamino) ethylamine-l-glutamate] (mPEG-b-P(DPA-DE)LG) and applied to act as an intelligent nanocarrier system for magnetic resonance imaging (MRI). The mPEG-b-P(DPA-DE)LG copolymer was synthesized by a typical ring opening polymerization of N-carboxyanhydrides (NCAs-ROP) using mPEG-NH2 as a macroinitiator, and two types of amine-terminated dopamine groups and p
: A higher K value at baseline DCE-MRI suggested a poor ablation efficacy of MR-HIFU therapy for symptomatic uterine fibroids.
Purpose To determine the exchange parameters for the CEST of phosphocreatine (PCrCEST) in phantoms and to characterize PCrCEST in vivo in the muscle at different saturation powers and magnetic fields. Methods Exchange parameters were measured in PCr solutions using varying saturation power at 15.2 T. Z‐spectra were analyzed using multipool Lorentzian fitting in the hindlimb using various powers at 2 different fields: 9.4 T and 15.2 T. Modulation of PCr signal in PCrCEST and phosphorus MRS was ob
Water-insoluble anticancer drugs, including paclitaxel, present severe clinical side effects when administered to patients, primarily associated with the toxicity of reagents used to solubilize the drugs. In efforts to develop alternative formulations of water-insoluble anticancer drugs suitable for intravenous administration, we developed biocompatible anticancer therapeutic solid lipid nanoparticles (SLNs), mimicking the structure and composition of natural particles, low-density lipoproteins
Nanoparticle (NP) based model carriers present an emerging strategy for protein delivery. However, constructing a multifunctional nanocarrier with high loading capacity, diagnostic imaging capacity, and controlled release capability is a tremendous challenge for protein delivery systems. Thus, we herein report on the fabrication of redox-responsive magnetic nanovectors (termed RMNs) through self- assembly of Fe 3 O 4 NPs and redox-responsive polymer ligands, which could effectively transport pro